Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Bilateral Salpingectomy for Ovarian Cancer Prevention

Am J Obstet Gynecol; ePub 2016 Oct 31; Hanley, et al

Hysterectomy with bilateral salpingectomy is significantly increasing in the US and is not associated with increased risks of postoperative complications, a recent study found. The Nationwide Inpatient Sample identified women aged ≥15 years without gynecologic cancer who underwent inpatient hysterectomy or tubal sterilization, with and without bilateral salpingectomy, between 2008 and 2013. Researchers found:

  • 425,180 women were included, representing a national cohort of 2,036,449 women.
  • There was an increase in the uptake of hysterectomy with bilateral salpingectomy of 371% across the study period.
  • There were only 1,195 salpingectomies for sterilization.
  • There was no increased risk for blood transfusion post-operative complications, post-operative infections, or fevers in the women who had hysterectomy with bilateral salpingectomy compared with those undergoing hysterectomy alone.


Hanley GE, McAlpine JN, Pearce CL, Miller D. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States. [Published online ahead of print October 31, 2016]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2016.10.035.